Net Income

The biopharma firm projects massive sales from its current drugs and bets big on a new Alzheimer's therapy, signaling a pivotal year of growth and innovation.

Samsara's 2025 data from 90B miles reveals AI tools led to a 73% lower crash rate, major fuel savings, and a new standard for connected operations.

Genomics giant Illumina launches a vast biological dataset with pharma partners, aiming to train AI and revolutionize how we find new medicines.

Blackbaud's latest accelerator cohort goes beyond code, backing diverse founders and AI-driven tools to redefine efficiency and impact in the nonprofit sector.

A new report shows a historic 28-38% drop in US-China trade, with Southeast Asian nations emerging as the big winners in a permanent supply chain shift.

With 1.2M engineers and soaring CAD model use, Supplyframe's milestone shows how integrated data is revolutionizing electronics from design to supply chain.

A new method lets employees teach themselves using AI. We explore the promise of personalized upskilling and the practical and ethical hurdles ahead.

A revolutionary bone graft that accelerates healing is now approved for more spinal surgeries, offering new hope to patients with chronic back pain.

Vericel posts strong 2025 results driven by its MACI cartilage therapy. The biotech leader is now investing in a new facility and a clinical trial for ankle repair.

Amid rising cyber threats, Availity’s award-winning framework promises a 5-day recovery, challenging the industry to move beyond defense to resilience.

AI promises to slash doctor burnout and paperwork, giving physicians more time with patients while boosting practice profitability. But can it deliver?

The AI firm announced record 2025 growth, leveraging deep partnerships with Google and Adobe to deliver award-winning, practical marketing solutions.

Kye Pharma brings SLENYTO®, a first-of-its-kind prescription sleep aid, to Canada, offering relief to children with ASD and SMS and their families.

Nukkleus Inc. completes its acquisition of Star 26 Capital, pivoting to defense tech and aiming to fix critical supply chain issues amid market volatility.

Amid market pressures, VirTra showcases its advanced training simulators at SHOT Show, betting on immersive tech to redefine law enforcement training.

A new leveraged ETF offers traders a 2x daily bet on lunar pioneer Intuitive Machines, igniting debate over speculation and risk in the new space economy.

goHappy launches Smart Reply, an app-free tool using simple text messages to bring structured, two-way communication to frontline teams, replacing messy group chats.

MedTech firm Lifeward is acquiring Oramed's oral insulin tech, despite a past trial failure, in a high-stakes deal that could redefine both companies.

Medical device firm CVRx is under investigation after its stock nosedived. Did management mislead investors about its salesforce stability?

As cannabis moves to Schedule III, a top consulting firm unveils expert witness and lab services to navigate a new landscape of regulation and litigation.